Literature DB >> 20688052

Biological variability of glycated hemoglobin.

Federica Braga1, Alberto Dolci, Andrea Mosca, Mauro Panteghini.   

Abstract

BACKGROUND: The measurement of glycated hemoglobin (HbA(1c)) has a pivotal role in monitoring glycemic state in diabetic patients. Furthermore, the American Diabetes Association has recently recommended the use of HbA(1c) for diabetes diagnosis, but a clear definition of the clinically allowable measurement error is still lacking. Information on biological variability of the analyte can be used to achieve this goal.
METHODS: We systematically reviewed the published studies on the biological variation of HbA(1c) to check consistency of available data in order to accurately define analytical goals.
RESULTS: The nine recruited studies were limited by choice of analytic methodology, population selection, protocol application and statistical analyses.
CONCLUSIONS: There is an urgent need to determine biological variability of HbA(1c) using a specific and traceable assay, appropriate protocol and appropriate statistical evaluation of data. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688052     DOI: 10.1016/j.cca.2010.07.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus.

Authors:  Yu-Fan Yang; Wen-Qing Zhu; Kuan Cheng; Qing-Xing Chen; Ye Xu; Yang Pang; Gui-Jian Liu; Jun-Bo Ge
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Biological Variation of Chloride and Sodium in Sweat Obtained by Pilocarpine Iontophoresis in Adults: How Sure are You About Sweat Test Results?

Authors:  Philippe Willems; Steven Weekx; Anissa Meskal; Sofie Schouwers
Journal:  Lung       Date:  2017-02-27       Impact factor: 2.584

3.  Diabetes Mellitus and Tinnitus: an Epidemiology Study.

Authors:  Seyed Hasan Golboei Mousavi; Batoolsadat Sajadinejad; Sina Khorsandi; Amin Farhadi
Journal:  Maedica (Bucur)       Date:  2021-12

Review 4.  Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk.

Authors:  Antonino Di Pino; Francesca Urbano; Salvatore Piro; Francesco Purrello; Agata Maria Rabuazzo
Journal:  World J Diabetes       Date:  2016-10-15

5.  Evaluation of the longitudinal deformation of the left ventricular myocardium in subjects with impaired fasting glucose with and without increased glycated hemoglobin.

Authors:  Niloofar Akhavan-Khaleghi; Ali Hosseinsabet
Journal:  Anatol J Cardiol       Date:  2018-01-24       Impact factor: 1.596

6.  Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes.

Authors:  Shunsuke Yamazaki; Tatsuro Takano; Koji Tachibana; Soichiro Takeda; Yasuo Terauchi
Journal:  Diabetes Ther       Date:  2022-07-06       Impact factor: 3.595

7.  Puerarin Improves Diabetic Aorta Injury by Inhibiting NADPH Oxidase-Derived Oxidative Stress in STZ-Induced Diabetic Rats.

Authors:  Wenping Li; Wenwen Zhao; Qin Wu; Yuanfu Lu; Jingshan Shi; Xiuping Chen
Journal:  J Diabetes Res       Date:  2016-01-06       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.